Symbolbild · KI-generiert
C4 Therapeutics, Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
C4 Therapeutics develops degrader molecules that selectively tag disease-causing proteins for degradation by the cellular proteasome. The technology platform (TORPEDO) aims to eliminate proteins that cannot be addressed by conventional inhibitors. The focus is on oncology and further indications with difficult-to-drug target proteins.
Short profile generated automatically and checked for plausibility. A full editorial profile follows once we cover the company.
Share price
Price data from TradingView, possibly delayed. Not investment advice.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| C4 Therapeutics, Inc. | CCCC | NASDAQ | 385 Mio. USD |
| Evolus, Inc. | EOLS | NASDAQ | 385 Mio. USD |
| Canopy Growth Corporation | WEED | TSX | 389 Mio. USD |
| Atea Pharmaceuticals, Inc. | AVIR | NASDAQ | 376 Mio. USD |
| X4 Pharmaceuticals, Inc. | XFOR | NASDAQ | 375 Mio. USD |
| Autolus Therapeutics plc | AUTL | NASDAQ | 397 Mio. USD |
| Larimar Therapeutics, Inc. | LRMR | NASDAQ | 397 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.